Market Overview

Trade CBD stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
11/07/17Credit SuisseUpgradesNeutralOutperform
11/03/16HSBCUpgradesReduceHold
11/09/15NomuraDowngradesBuyNeutral
Show more Loading articles...

Earnings View Earnings

Q3 2018 EST Actual Surprise
EPS: 0.21 0.14 -0.07
Rev: 3.31B
Q4 2018 EST Actual Surprise
EPS: 0.25 Expected
2019-02-20
Rev:

Company Profile